Economic impact of pharmacists' interventions in asthma management: a systematic review

Objective: The purpose of this study was to review in a systematically way the studies that investigated the economic impact of clinical pharmacist services delivered to asthma individuals. Methods: A systematic survey was conducted in the PubMed, Scopus, Lilacs and Cochrane databases aiming to gra...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Gabriel R. FREITAS, Juliana U. SANTOS, Juliana S. FRANÇA, Rodrigo S. PINTO, Brayan V. SEIXAS
Formato:	article
Lenguaje:	EN PT
Publicado:	Sociedade Brasileira de Farmácia Hospitalar e Serviços de Saúde 2021
Materias:	Public aspects of medicine RA1-1270 Pharmacy and materia medica RS1-441 Therapeutics. Pharmacology RM1-950
Acceso en línea:	https://doaj.org/article/be16fd77d4cf42b68cb1e541db326de6
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:be16fd77d4cf42b68cb1e541db326de6
record_format	dspace
spelling	oai:doaj.org-article:be16fd77d4cf42b68cb1e541db326de62021-11-28T02:42:29ZEconomic impact of pharmacists' interventions in asthma management: a systematic review10.30968/rbfhss.2021.213.05872179-59242316-7750https://doaj.org/article/be16fd77d4cf42b68cb1e541db326de62021-09-01T00:00:00Zhttps://www.rbfhss.org.br/sbrafh/article/view/587https://doaj.org/toc/2179-5924https://doaj.org/toc/2316-7750 Objective: The purpose of this study was to review in a systematically way the studies that investigated the economic impact of clinical pharmacist services delivered to asthma individuals. Methods: A systematic survey was conducted in the PubMed, Scopus, Lilacs and Cochrane databases aiming to grade the economic evaluations published until January 2020. English, Spanish, Portuguese or French language articles were included if they evaluated a pharmaceutical intervention aiming asthma patients and also reported economic data about these interventions. There was no limitation regarding the study design or type of economic analysis. Two independent authors assessed and selected the studies, extracted the data, and measured risk of bias. Risk of bias was measured through the Cochrane’s risk of bias tool for randomized controlled trials and the Newcastle-Ottawa quality assessment scale for cohort studies. Results: 2,832 references were identified through the search strategy, but only seven studies met the inclusion criteria to be selected into the final analysis. Out of these seven articles, four consisted of cohort studies, and three consisted of randomized controlled trials. Instructional programs and patient counseling were the most usual components of pharmaceutical care interventions. Six articles showed statistically significant positive economic outcomes of pharmaceutical care interventions in asthma management. Moreover, pharmaceutical interventions were found to decrease hospitalizations, emergency visits, symptoms, and increase adherence to pharmacotherapy. Conclusions: Studies included showed acceptable and satisfactory cost-saving ratios, demonstrating the potential benefit of inserting the pharmacist into the multidisciplinary team. Nevertheless, long-term studies and randomized clinical trials are needed to establish solid evidence in order to expand the results found in this review to broader and different contexts. Gabriel R. FREITASJuliana U. SANTOSJuliana S. FRANÇARodrigo S. PINTOBrayan V. SEIXASSociedade Brasileira de Farmácia Hospitalar e Serviços de SaúdearticlePublic aspects of medicineRA1-1270Pharmacy and materia medicaRS1-441Therapeutics. PharmacologyRM1-950ENPTRevista Brasileira de Farmácia Hospitalar e Serviços de Saúde, Vol 12, Iss 3 (2021)
institution	DOAJ
collection	DOAJ
language	EN PT
topic	Public aspects of medicine RA1-1270 Pharmacy and materia medica RS1-441 Therapeutics. Pharmacology RM1-950
spellingShingle	Public aspects of medicine RA1-1270 Pharmacy and materia medica RS1-441 Therapeutics. Pharmacology RM1-950 Gabriel R. FREITAS Juliana U. SANTOS Juliana S. FRANÇA Rodrigo S. PINTO Brayan V. SEIXAS Economic impact of pharmacists' interventions in asthma management: a systematic review
description	Objective: The purpose of this study was to review in a systematically way the studies that investigated the economic impact of clinical pharmacist services delivered to asthma individuals. Methods: A systematic survey was conducted in the PubMed, Scopus, Lilacs and Cochrane databases aiming to grade the economic evaluations published until January 2020. English, Spanish, Portuguese or French language articles were included if they evaluated a pharmaceutical intervention aiming asthma patients and also reported economic data about these interventions. There was no limitation regarding the study design or type of economic analysis. Two independent authors assessed and selected the studies, extracted the data, and measured risk of bias. Risk of bias was measured through the Cochrane’s risk of bias tool for randomized controlled trials and the Newcastle-Ottawa quality assessment scale for cohort studies. Results: 2,832 references were identified through the search strategy, but only seven studies met the inclusion criteria to be selected into the final analysis. Out of these seven articles, four consisted of cohort studies, and three consisted of randomized controlled trials. Instructional programs and patient counseling were the most usual components of pharmaceutical care interventions. Six articles showed statistically significant positive economic outcomes of pharmaceutical care interventions in asthma management. Moreover, pharmaceutical interventions were found to decrease hospitalizations, emergency visits, symptoms, and increase adherence to pharmacotherapy. Conclusions: Studies included showed acceptable and satisfactory cost-saving ratios, demonstrating the potential benefit of inserting the pharmacist into the multidisciplinary team. Nevertheless, long-term studies and randomized clinical trials are needed to establish solid evidence in order to expand the results found in this review to broader and different contexts.
format	article
author	Gabriel R. FREITAS Juliana U. SANTOS Juliana S. FRANÇA Rodrigo S. PINTO Brayan V. SEIXAS
author_facet	Gabriel R. FREITAS Juliana U. SANTOS Juliana S. FRANÇA Rodrigo S. PINTO Brayan V. SEIXAS
author_sort	Gabriel R. FREITAS
title	Economic impact of pharmacists' interventions in asthma management: a systematic review
title_short	Economic impact of pharmacists' interventions in asthma management: a systematic review
title_full	Economic impact of pharmacists' interventions in asthma management: a systematic review
title_fullStr	Economic impact of pharmacists' interventions in asthma management: a systematic review
title_full_unstemmed	Economic impact of pharmacists' interventions in asthma management: a systematic review
title_sort	economic impact of pharmacists' interventions in asthma management: a systematic review
publisher	Sociedade Brasileira de Farmácia Hospitalar e Serviços de Saúde
publishDate	2021
url	https://doaj.org/article/be16fd77d4cf42b68cb1e541db326de6
work_keys_str_mv	AT gabrielrfreitas economicimpactofpharmacistsinterventionsinasthmamanagementasystematicreview AT julianausantos economicimpactofpharmacistsinterventionsinasthmamanagementasystematicreview AT julianasfranca economicimpactofpharmacistsinterventionsinasthmamanagementasystematicreview AT rodrigospinto economicimpactofpharmacistsinterventionsinasthmamanagementasystematicreview AT brayanvseixas economicimpactofpharmacistsinterventionsinasthmamanagementasystematicreview
_version_	1718408462620164096

Economic impact of pharmacists' interventions in asthma management: a systematic review

Ejemplares similares